Trypanosome resistance to human innate immunity: targeting Achilles' heel

被引:16
|
作者
Stephens, Natalie A. [1 ]
Kieft, Rudo [1 ]
MacLeod, Annette [2 ]
Hajduk, Stephen L. [1 ]
机构
[1] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA
[2] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow G61 1QH, Lanark, Scotland
基金
英国惠康基金;
关键词
African trypanosomes; innate immunity; high density lipoproteins; haptoglobin; apolipoprotein L-1; haptoglobin related protein; serum resistance associated protein; trypanosome lytic factor; HIGH-DENSITY-LIPOPROTEIN; VARIANT SURFACE GLYCOPROTEIN; HAPTOGLOBIN-RELATED PROTEIN; NORMAL HUMAN-SERUM; GAMBIENSE GROUP 1; LYTIC FACTOR; AFRICAN TRYPANOSOMES; BRUCEI-RHODESIENSE; TRYPANOLYTIC FACTOR; SCAVENGER RECEPTOR;
D O I
10.1016/j.pt.2012.09.002
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Trypanosome lytic factors (TLFs) are powerful, naturally occurring toxins in humans that provide sterile protection against infection by several African trypanosomes. These trypanocidal complexes predominantly enter the parasite by binding to the trypanosome haptoglobin/hemoglobin receptor (HpHbR), trafficking to the lysosome, causing membrane damage and, ultimately, cell lysis. Despite TLF-mediated immunity, the parasites that cause human African Trypanosomiasis (HAT), Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense, have developed independent mechanisms of resistance to TLF killing. In this review we describe the parasite defenses that allow trypanosome infections of humans and discuss how targeting these apparent strengths of the parasite may reveal their Achilles' heel, leading to new approaches in the treatment of HAT.
引用
收藏
页码:539 / 545
页数:7
相关论文
共 50 条
  • [41] Targeting Innate Immunity in Cancer Therapy
    Rameshbabu, Srikrishnan
    Labadie, Brian W.
    Argulian, Anna
    Patnaik, Akash
    VACCINES, 2021, 9 (02) : 1 - 26
  • [42] Targeting Innate Immunity in Glioma Therapy
    Gillard, Andrew G.
    Shin, Dong Ho
    Hampton, Lethan A.
    Lopez-Rivas, Andres
    Parthasarathy, Akhila
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [43] Targeting Innate Immunity to Treat Cancer
    Austin, Matthew
    Kluger, Harriet
    CANCERS, 2020, 12 (10)
  • [44] Antiviral innate immunity targeting RNA
    Takeuchi, Osamu
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 18 - 18
  • [45] Cancer immunotherapy targeting innate immunity
    Ma, Zhifeng
    Li, Wen
    Hata, Masaki
    El-Darawish, Yosif
    Yamanishi, Kyosuke
    Yamanishi, Hiromichi
    Tanaka, Yoshimasa
    Okamura, Haruki
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S73 - S73
  • [46] Targeting innate immunity for tuberculosis vaccination
    Khader, Shabaana A.
    Divangahi, Maziar
    Hanekom, Willem
    Hill, Philip C.
    Maeurer, Markus
    Makar, Karen W.
    Mayer-Barber, Katrin D.
    Mhlanga, Musa M.
    Nemes, Elisa
    Schlesinger, Larry S.
    van Crevel, Reinout
    Vankalayapati, Ramakrishna
    Xavier, Ramnik J.
    Netea, Mihai G.
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (09): : 3482 - 3491
  • [47] Targeting the Achilles Heel of Mosquito-Borne Viruses for Antiviral Therapy
    Jackman, Joshua A.
    Shi, Pei-Yong
    Cho, Nam-Joon
    ACS INFECTIOUS DISEASES, 2019, 5 (01): : 4 - 8
  • [48] Small Molecule Inhibitors Targeting the "Achilles' Heel" of Androgen Receptor Activity
    Sadar, Marianne D.
    CANCER RESEARCH, 2011, 71 (04) : 1208 - 1213
  • [49] Is CTLA4 targeting the Achilles' heel of Merkel cell carcinoma?
    Wu, Richard Cheng Han
    Kendra, Kari Lynn
    Blakaj, Dukagjin
    Shah, Hiral A.
    Jeter, Joanne M.
    Verschraegen, Claire F.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Reply to "Targeting cholesterol homeostasis through inhibiting: An Achilles' heel for glioblastoma?"
    Gu, Danling
    You, Hao
    Gao, Jiancheng
    You, Yongping
    Rich, Jeremy N.
    Zhang, Junxia
    Wang, Xiuxing
    NEURO-ONCOLOGY, 2023,